BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8893761)

  • 1. SAS is amplified predominantly in surface osteosarcoma.
    Noble-Topham SE; Burrow SR; Eppert K; Kandel RA; Meltzer PS; Bell RS; Andrulis IL
    J Orthop Res; 1996 Sep; 14(5):700-5. PubMed ID: 8893761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression through amplification of genes in chromosome region 17p11.2 approximately p12 in high-grade osteosarcoma.
    van Dartel M; Redeker S; Bras J; Kool M; Hulsebos TJ
    Cancer Genet Cytogenet; 2004 Jul; 152(1):8-14. PubMed ID: 15193436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2.
    Forus A; Flørenes VA; Maelandsmo GM; Meltzer PS; Fodstad O; Myklebost O
    Cell Growth Differ; 1993 Dec; 4(12):1065-70. PubMed ID: 8117620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sporadic amplification of the MYC gene in human osteosarcomas.
    Ladanyi M; Park CK; Lewis R; Jhanwar SC; Healey JH; Huvos AG
    Diagn Mol Pathol; 1993 Sep; 2(3):163-7. PubMed ID: 8287230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of the gli gene in childhood sarcomas.
    Roberts WM; Douglass EC; Peiper SC; Houghton PJ; Look AT
    Cancer Res; 1989 Oct; 49(19):5407-13. PubMed ID: 2766305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COPS3 amplification and clinical outcome in osteosarcoma.
    Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
    Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-amplification and overexpression of CDK4, SAS and MDM2 occurs frequently in human parosteal osteosarcomas.
    Wunder JS; Eppert K; Burrow SR; Gokgoz N; Bell RS; Andrulis IL
    Oncogene; 1999 Jan; 18(3):783-8. PubMed ID: 9989829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma.
    Onda M; Matsuda S; Higaki S; Iijima T; Fukushima J; Yokokura A; Kojima T; Horiuchi H; Kurokawa T; Yamamoto T
    Cancer; 1996 Jan; 77(1):71-8. PubMed ID: 8630943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of retinoblastoma susceptible gene accompanied by c-myc amplification in human bone and soft tissue tumors.
    Ozaki T; Ikeda S; Kawai A; Inoue H; Oda T
    Cell Mol Biol (Noisy-le-grand); 1993 Mar; 39(2):235-42. PubMed ID: 8513277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative genomic hybridization of low-grade central osteosarcoma.
    Tarkkanen M; Böhling T; Gamberi G; Ragazzini P; Benassi MS; Kivioja A; Kallio P; Elomaa I; Picci P; Knuutila S
    Mod Pathol; 1998 May; 11(5):421-6. PubMed ID: 9619593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant astrocytoma-derived region of common amplification in chromosomal band 17p12 is frequently amplified in high-grade osteosarcomas.
    Hulsebos TJ; Bijleveld EH; Oskam NT; Westerveld A; Leenstra S; Hogendoorn PC; Bras J
    Genes Chromosomes Cancer; 1997 Apr; 18(4):279-85. PubMed ID: 9087567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation.
    Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J
    Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of HER2/neu expression by real-time PCR and fluorescent in situ hybridization analysis in low-grade osteosarcoma.
    Lee WI; Bacchni P; Bertoni F; Maeng YH; Park YK
    Oncol Rep; 2004 Jul; 12(1):125-8. PubMed ID: 15201972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SAS, a gene amplified in human sarcomas, encodes a new member of the transmembrane 4 superfamily of proteins.
    Jankowski SA; Mitchell DS; Smith SH; Trent JM; Meltzer PS
    Oncogene; 1994 Apr; 9(4):1205-11. PubMed ID: 8134123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
    Park HR; Min K; Kim HS; Jung WW; Park YK
    Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification of the genes BCHE and SLC2A2 in 40% of squamous cell carcinoma of the lung.
    Brass N; Rácz A; Heckel D; Remberger K; Sybrecht GW; Meese EU
    Cancer Res; 1997 Jun; 57(11):2290-4. PubMed ID: 9187134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular genetic considerations in osteosarcoma.
    Hansen MF
    Clin Orthop Relat Res; 1991 Sep; (270):237-46. PubMed ID: 1679382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays.
    Squire JA; Pei J; Marrano P; Beheshti B; Bayani J; Lim G; Moldovan L; Zielenska M
    Genes Chromosomes Cancer; 2003 Nov; 38(3):215-25. PubMed ID: 14506695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of SV40 in human osteosarcoma DNA.
    Mendoza SM; Konishi T; Miller CW
    Oncogene; 1998 Nov; 17(19):2457-62. PubMed ID: 9824156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amplification and overexpression of genes in 17p11.2 ~ p12 in osteosarcoma.
    van Dartel M; Hulsebos TJ
    Cancer Genet Cytogenet; 2004 Aug; 153(1):77-80. PubMed ID: 15325100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.